1.
First human study in treatment of unresectable liver metastases from colorectal cancer with irinotecan-loaded beads (DEBIRI).
Eichler K,
Zangos S,
Mack MG,
Hammerstingl R,
Gruber-Rouh T,
Gallus C,
Vogl TJ.
Int J Oncol.
2012 Jul 25.
doi: 10.3892/ijo.2012.1572.
2.
Trans-arterial chemoembolization of metastatic colorectal carcinoma to the liver adopting DC Bead®,
drug-eluting bead loaded with irinotecan: results of a phase II clinical study.
Aliberti C,
Fiorentini G,
Muzzio PC,
Pomerri F,
Tilli M,
Dallara S,
Benea G.
Anticancer Res.
2011 Dec;31(12):4581-7.
3.
Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report.
Martin RC,
Robbins K,
Tomalty D,
O'Hara R,
Bosnjakovic P,
Padr R,
Rocek M,
Slauf F,
Scupchenko A,
Tatum C.
World J Surg Oncol.
2009 Nov 3;7:80.
doi: 10.1186/1477-7819-7-80.
4.
TACE of liver metastases from colorectal cancer adopting irinotecan-eluting beads: beneficial effect of palliative intra-arterial lidocaine and post-procedure supportive therapy on the control of side effects.
Fiorentini G,
Aliberti C,
Benea G,
Montagnani F,
Mambrini A,
Ballardini PL,
Cantore M.
Hepatogastroenterology.
2008 Nov-Dec;55(88):2077-82.
5.
Intraarterial hepatic chemoembolization of liver metastases from colorectal cancer adopting irinotecan-eluting beads: results of a phase II clinical study.
Fiorentini G,
Aliberti C,
Turrisi G,
Del Conte A,
Rossi S,
Benea G,
Giovanis P.
In Vivo.
2007 Nov-Dec;21(6):1085-91.
6.
Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: preliminary results.
Aliberti C,
Tilli M,
Benea G,
Fiorentini G.
Anticancer Res.
2006 Sep-Oct;26(5B):3793-5.